FDA Inspection
Zhejiang Huahai Pharmaceutical Co., Ltd.Zhejiang Huahai Pharmaceutical Co., Ltd. – FDA Inspection, Jan 24, 2025
Record Details
This FDA Inspection record concerns Zhejiang Huahai Pharmaceutical Co., Ltd., with an inspection on January 24, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6c8aed33-ef33-4a48-97c2-992934935373
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1259818
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Zhejiang Huahai Pharmaceutical Co., Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Office of Inspections and Investigations | |
| July 2, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | Not classified | Office of Inspections and Investigations | |
| May 31, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Zhejiang Huahai Pharmaceutical Co., Ltd.
- FDA Inspection 1319736 - 2026-04-24
- FDA Inspection 1149252 - 2021-07-02
- FDA Inspection 1094941 - 2019-06-28
- FDA Inspection 1093250 - 2019-05-31
- FDA Inspection 1042575 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.